What it's for (Indications)
- Ampicillin and cloxacillin, a synergistic combination antibiotic, is clinically indicated for the treatment of a wide array of bacterial infections caused by susceptible organisms.
- This includes, but is not limited to, respiratory tract infections (such as pneumonia, bronchitis, and pharyngitis), skin and soft tissue infections (e.
- g.
- , cellulitis, abscesses, infected wounds), urinary tract infections, bone and joint infections (like osteomyelitis), septicaemia, bacterial endocarditis, and other systemic infections.
- Its broad spectrum, encompassing Gram-positive organisms (including beta-lactamase-producing Staphylococcus aureus due to cloxacillin) and certain Gram-negative bacteria (due to ampicillin), makes it particularly valuable for empiric therapy in mixed infections or when the causative agent's penicillinase production status is unknown.
- The decision to prescribe this medication should be based on clinical judgment, susceptibility testing, and local epidemiological patterns of resistance, ensuring optimal therapeutic outcomes and minimizing the risk of resistance development.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The precise dosage regimen for ampicillin and cloxacillin must be determined by a healthcare professional based on the severity and type of infection, the patient's age, weight, renal function, and the chosen route of administration (oral, intramuscular, or intravenous). For adults with moderate to severe infections, a common oral dosage typically ranges from 250 mg to 500 mg (of each component) administered every 6 hours. In more severe systemic infections, or for patients unable to take oral medication, parenteral routes may be employed with corresponding dose adjustments. Pediatric dosing is weight-based and calculated per kilogram of body weight, and careful consideration must be given to renal impairment in all patient populations, which may necessitate dose reduction or extended dosing intervals to prevent drug accumulation and potential toxicity. Adherence to the prescribed duration of therapy is crucial to ensure complete eradication of the infection and prevent the development of antibiotic resistance, even if symptoms improve earlier. |
Safety & Warnings
Common Side Effects
- Patients receiving ampicillin and cloxacillin may experience a range of side effects, varying in frequency and severity.
- Common adverse reactions include gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal pain, and candidiasis (oral or vaginal thrush).
- Hypersensitivity reactions are also prevalent and can manifest as skin rashes (maculopapular rash, urticaria), pruritus, and drug fever.
- More serious, albeit less common, adverse effects necessitate immediate medical attention.
- These include severe allergic reactions (anaphylaxis, angiooedema), severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), pseudomembranous colitis caused by Clostridioides difficile, hepatotoxicity (manifesting as elevated liver enzymes or cholestatic jaundice), hematologic abnormalities (e.
- g.
- , anemia, leukopenia, thrombocytopenia, eosinophilia), interstitial nephritis, and central nervous system toxicity (seizures), particularly in patients with impaired renal function or those receiving very high doses.
- Patients should be advised to report any unusual or severe symptoms promptly.
Serious Warnings
- Black Box Warning: While a formal 'Black Box Warning' as designated by the U.S. Food and Drug Administration (FDA) is not typically assigned to ampicillin and cloxacillin as a combination, the potential for severe, life-threatening hypersensitivity reactions (anaphylaxis) is a critical safety concern that warrants the highest level of vigilance, akin to what would be conveyed in such a warning. Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy, including ampicillin and cloxacillin. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. Before initiating therapy with ampicillin and cloxacillin, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. If an allergic reaction occurs, ampicillin and cloxacillin should be discontinued immediately and appropriate alternative therapy instituted. Severe anaphylactic reactions require immediate emergency treatment with epinephrine, oxygen, intravenous steroids, and airway management, including intubation.
- Several critical warnings and precautions are associated with the use of ampicillin and cloxacillin.
- Foremost among these is the risk of hypersensitivity reactions.
- Patients with a history of penicillin allergy or severe allergic reactions to other beta-lactam antibiotics (e.
- g.
- , cephalosporins) are at increased risk and should not receive this medication.
- Close monitoring for signs of an allergic reaction (e.
- g.
- , rash, pruritus, dyspnea, angioedema) is essential, especially during the initial doses.
- The development of Clostridioides difficile-associated diarrhea (CDAD) is a significant concern, which can range from mild diarrhea to fatal colitis and may occur during or after antibiotic therapy.
- Patients with infectious mononucleosis are at an exceptionally high risk of developing a generalized maculopapular rash when treated with ampicillin; therefore, ampicillin and cloxacillin should generally be avoided in these patients.
- Prolonged use of this antibiotic combination can lead to superinfection with non-susceptible bacteria or fungi, necessitating careful monitoring.
- Renal and hepatic function should be regularly monitored, particularly in patients with pre-existing impairment, as dose adjustments may be necessary to prevent drug accumulation and toxicity.
- Concomitant use with oral contraceptives may reduce their efficacy, and patients should be advised to use alternative birth control methods.
How it Works (Mechanism of Action)
Ampicillin and cloxacillin are both bactericidal beta-lactam antibiotics, exerting their effect by interfering with bacterial cell wall synthesis. Their primary mechanism involves binding to specific enzymes known as penicillin-binding proteins (PBPs) located within the bacterial cell wall. These PBPs are crucial for catalyzing the transpeptidation reactions involved in peptidoglycan synthesis, a vital structural component of the bacterial cell wall. By competitively inhibiting these enzymes, ampicillin and cloxacillin prevent the formation of a stable, rigid cell wall, leading to weakened bacterial cell walls, increased osmotic pressure, and ultimately, bacterial lysis and death. Ampicillin, an aminopenicillin, provides broad-spectrum activity against a range of susceptible Gram-positive and Gram-negative organisms, though it is susceptible to degradation by bacterial beta-lactamase enzymes. Cloxacillin, an isoxazolyl penicillin, is specifically designed to be resistant to degradation by staphylococcal beta-lactamases, thereby effectively treating infections caused by penicillinase-producing Staphylococcus aureus strains, which would otherwise inactivate ampicillin. The combination leverages these complementary actions for broader empirical coverage.